Literature DB >> 10646884

Loss of heterozygosity at 7p in Wilms' tumour development.

R M Powlesland1, A K Charles, K T Malik, P A Reynolds, S Pires, M Boavida, K W Brown.   

Abstract

Chromosome 7p alterations have been implicated in the development of Wilms' tumour (WT) by previous studies of tumour cytogenetics, and by our analysis of a constitutional translocation (t(1;7)(q42;p15)) in a child with WT and radial aplasia. We therefore used polymorphic microsatellite markers on 7p for a loss of heterozygosity (LOH) study, and found LOH in seven out of 77 informative WTs (9%). The common region of LOH was 7p15-7p22, which contains the region disrupted by the t(1;7) breakpoint. Four WTs with 7p LOH had other genetic changes; a germline WT1 mutation with 11p LOH, LOH at 11p, LOH at 16q, and loss of imprinting of IGF2. Analysis of three tumour-associated lesions from 7p LOH cases revealed a cystic nephroma-like area also having 7p LOH. However, a nephrogenic rest and a contralateral WT from the two other cases showed no 7p LOH. No particular clinical phenotype was associated with the WTs which showed 7p LOH. The frequency and pattern of 7p LOH demonstrated in our studies indicate the presence of a tumour suppressor gene at 7p involved in the development of Wilms' tumour.

Entities:  

Mesh:

Year:  2000        PMID: 10646884      PMCID: PMC2363297          DOI: 10.1054/bjoc.1999.0922

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  49 in total

Review 1.  Microsatellites for linkage analysis of genetic traits.

Authors:  C M Hearne; S Ghosh; J A Todd
Journal:  Trends Genet       Date:  1992-08       Impact factor: 11.639

2.  Wilms' tumour and a de novo (1;7) translocation in a child with bilateral radial aplasia.

Authors:  M Hewitt; P W Lunt; A Oakhill
Journal:  J Med Genet       Date:  1991-06       Impact factor: 6.318

3.  Dinucleotide repeat polymorphisms at the D16S260, D16S261, D16S265, D16S266, and D16S267 loci.

Authors:  J L Weber; A E Kwitek; P E May
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

4.  Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus.

Authors:  K M Call; T Glaser; C Y Ito; A J Buckler; J Pelletier; D A Haber; E A Rose; A Kral; H Yeger; W H Lewis
Journal:  Cell       Date:  1990-02-09       Impact factor: 41.582

5.  Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping.

Authors:  M Gessler; A Poustka; W Cavenee; R L Neve; S H Orkin; G A Bruns
Journal:  Nature       Date:  1990-02-22       Impact factor: 49.962

6.  Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumor cells.

Authors:  A E Reeve; S A Sih; A M Raizis; A P Feinberg
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

7.  Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour.

Authors:  O Ogawa; M R Eccles; J Szeto; L A McNoe; K Yun; M A Maw; P J Smith; A E Reeve
Journal:  Nature       Date:  1993-04-22       Impact factor: 49.962

8.  Correlation of chromosome abnormalities with histological and clinical features in Wilms' and other childhood renal tumors.

Authors:  Y Kaneko; C Homma; N Maseki; M Sakurai; J Hata
Journal:  Cancer Res       Date:  1991-11-01       Impact factor: 12.701

9.  Relaxation of imprinted genes in human cancer.

Authors:  S Rainier; L A Johnson; C J Dobry; A J Ping; P E Grundy; A P Feinberg
Journal:  Nature       Date:  1993-04-22       Impact factor: 49.962

10.  A third Wilms' tumor locus on chromosome 16q.

Authors:  M A Maw; P E Grundy; L J Millow; M R Eccles; R S Dunn; P J Smith; A P Feinberg; D J Law; M C Paterson; P E Telzerow
Journal:  Cancer Res       Date:  1992-06-01       Impact factor: 12.701

View more
  7 in total

1.  High-resolution genomic profiling of an adult Wilms' tumor: evidence for a pathogenesis distinct from corresponding pediatric tumors.

Authors:  Jenny Karlsson; Linda Holmquist Mengelbier; Peter Elfving; David Gisselsson Nord
Journal:  Virchows Arch       Date:  2011-09-23       Impact factor: 4.064

Review 2.  Candidate genes and potential targets for therapeutics in Wilms' tumour.

Authors:  Christopher Blackmore; Max J Coppes; Aru Narendran
Journal:  Clin Transl Oncol       Date:  2010-09       Impact factor: 3.405

3.  Genes Downregulated in Endometriosis Are Located Near the Known Imprinting Genes.

Authors:  Hiroshi Kobayashi; Yumi Higashiura; Natsuki Koike; Juria Akasaka; Chiharu Uekuri; Kana Iwai; Emiko Niiro; Sachiko Morioka; Yuki Yamada
Journal:  Reprod Sci       Date:  2014-03-10       Impact factor: 3.060

4.  Neuroprotection by histone deacetylase-related protein.

Authors:  Brad E Morrison; Nazanin Majdzadeh; Xiaoguang Zhang; Aaron Lyles; Rhonda Bassel-Duby; Eric N Olson; Santosh R D'Mello
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

5.  Overexpression of HDAC9 promotes oral squamous cell carcinoma growth, regulates cell cycle progression, and inhibits apoptosis.

Authors:  Bhawna Rastogi; Satish K Raut; Naresh K Panda; Vidya Rattan; Bishan D Radotra; Madhu Khullar
Journal:  Mol Cell Biochem       Date:  2016-03-18       Impact factor: 3.396

6.  Loss of heterozygosity and SOSTDC1 in adult and pediatric renal tumors.

Authors:  Kimberly R Blish; Kathryn A Clausen; Gregory A Hawkins; A Julian Garvin; Mark C Willingham; Julie C Turner; Frank M Torti; Suzy V Torti
Journal:  J Exp Clin Cancer Res       Date:  2010-11-16

7.  Loss of heterozygosity at 2q37 in sporadic Wilms' tumor: putative role for miR-562.

Authors:  Kylie M Drake; E Cristy Ruteshouser; Rachael Natrajan; Phyllis Harbor; Jenny Wegert; Manfred Gessler; Kathy Pritchard-Jones; Paul Grundy; Jeffrey Dome; Vicki Huff; Chris Jones; Micheala A Aldred
Journal:  Clin Cancer Res       Date:  2009-09-29       Impact factor: 12.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.